Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / COM
-
Number of holders
-
107
-
Total 13F shares, excl. options
-
63,819,650
-
Shares change
-
+10,072,244
-
Total reported value, excl. options
-
$215,650,821
-
Value change
-
+$33,681,613
-
Put/Call ratio
-
157%
-
Number of buys
-
53
-
Number of sells
-
-47
-
Price
-
$3.38
Significant Holders of CYMABAY THERAPEUTICS INC - COM (CBAY) as of Q4 2021
135 filings reported holding CBAY - CYMABAY THERAPEUTICS INC - COM as of Q4 2021.
CYMABAY THERAPEUTICS INC - COM (CBAY) has 107 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 63,819,650 shares
.
Largest 10 shareholders include Avoro Capital Advisors LLC (10,300,000 shares), TCG Crossover Management, LLC (5,905,400 shares), COMMODORE CAPITAL LP (5,419,896 shares), BlackRock Inc. (5,324,128 shares), VANGUARD GROUP INC (3,788,457 shares), BAKER BROS. ADVISORS LP (2,170,464 shares), MILLENNIUM MANAGEMENT LLC (2,070,787 shares), Nantahala Capital Management, LLC (2,000,142 shares), DAFNA Capital Management LLC (1,787,569 shares), and Foresite Capital Management IV, LLC (1,787,094 shares).
This table shows the top 107 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.